期刊文献+

mTSLP-V1/V2融合蛋白的真核表达与鉴定 被引量:1

Eukaryotic expression and characterization of mouse TSLP and HIV-1 gp120BAL V1/V2 fusion protein
下载PDF
导出
摘要 目的:将鼠胸腺基质淋巴细胞生成素(mouse thymic stromal lymphopoietin,mTSLP)与人免疫缺陷病毒1型(human immunodeficiency virus type 1,HIV-1)B亚型分离株BAL的gp120 V1/V2结构域在293F真核细胞表达体系中进行融合表达。方法:以真核表达质粒pCEP-Pu为载体,构建mTSLP与gp120BALV1V2融合基因的重组蛋白表达质粒pCTV1V2BAL。限制性酶切电泳与测序验证质粒构建正确后,使用PEI瞬时转染293F悬浮细胞,表达产物以SDS-PAGE与Western blot进行分析,并对纯化后重组蛋白的V1/V2抗原表位进行了ELISA分析。结果:SDS-PAGE、Western blot分析显示,在表观分子量35 kD至55 kD的范围内存在一条不均一的糖蛋白条带,并且能与抗mTSLP多克隆抗体和抗His标签单克隆抗体发生反应。HIV-1阳性病人血清能够识别mTSLP-V1/V2BAL上的HIV-1V1/V2抗原表位。结论:在293F中成功表达了mTSLP-V1/V2BAL融合蛋白,该蛋白具有HIV-1gp120BALV1/V2区的抗原表位,能够用于HIV-1 gp120 V1/V2亚单位疫苗的研究。 Objective:To express fusion protein of mouse thymic stromal lymphopoietin (TSLP) and HIV-1 gp120BAL V1/V2 subdomain in 293F cell.Methods:Full length of the V1V2 sequence from BAL isolate was fused with the C-terminus of mouse thymic stromal lymphopoietin (TSLP) and sub-cloned into pCEP-Pu vector to construct the eukaryotic expression plasmid-pCTV1V2BAL.The recombinant plasmid was confirmed by enzyme digestion and sequencing , then transfected into 293 F cells using PEI as a transfection reagent .The fusion protein was purified by metal chelate affinity chromatography and characterized by SDS -PAGE and Western blot . The epitopes of V1/V2 in fusion protein were identified by ELISA .Results:The SDS-PAGE and Western blot results showed that there were highly heterogeneous glycoprotein bands at the site between 35 kD and 55 kD, which reacted with anti-mTSLP rabbit polyclonal antibody and anti-His tag mouse monoclonal antibody .The ELISA analysis showed that antibodies to V 1/V2BAL existed in the sera of HIV-1 positive patients.Conclusion:The mTSLP-V1/V2 fusion protein was successfully expressed in 293F cells, which may be useful for HIV-1 vaccine research .
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2014年第5期582-586,共5页 Chinese Journal of Immunology
基金 国家自然科学基金面上项目(No.30870124) 科技部国际合作项目(No.2009DFA31260)的资助
关键词 人免疫缺陷病毒1型 gp120可变区1 2 鼠胸腺基质淋巴细胞生成素 293 F表达体系 融合蛋白 HIV-1 gp120 V1/V2 TSLP 293F expression system Fusion protein
  • 相关文献

参考文献1

二级参考文献17

  • 1颜瑾,王玉,李杰,马鹏飞,林鹏,邢辉,刁丽梅,邵一鸣.艾滋病病毒1型流行株分子流行病学调查[J].中国公共卫生,2005,21(1):90-91. 被引量:22
  • 2Burton D R,Desrosiers R C,Doms R W et al.HIV vaccine design andthe neutralizing antibody problem[J].Nature Immunology,2004;5(3):233-236.
  • 3Wu X,Yang Z,Li Y et al.Rational design of envelope identifiesbroadly neutralizing human monoclonal antibodies to HIV-1[J].Sci-ence,2010;329(5993):856-861.
  • 4Walker L M,Phogat S K,Chan-Hui P Y et al.Broad and potent neu-tralizing antibodies from an African donor reveal a new HIV-1 vaccinetarget[J].Science,2009;326(5950):285-288.
  • 5Emini E A,Schleif W A,Nunberg J H et al.Prevention of HIV-1 in-fection in chimpanzees by gp120 V3 domain-specific monoclonal anti-body[J].Nature,1992;355(6362):728-730.
  • 6Poveda E,Briz V,Quinones-Mateu M et al.HIV tropism:diagnostictools and implications for disease progression and treatment with entryinhibitors[J].Aids,2006;20(10):1359-1367.
  • 7Hu G,Liu J,Taylor K A et al.Structural comparison of HIV-1 enve-lope spikes with and without the V1/V2 Loop[J].J Virology,2011;85(6):2741-2750.
  • 8Stamatatos L,Cheng-Mayer C.An envelope modification that renders aprimary,neutralization-resistant clade B human immunodeficiency vi-rus type 1 isolate highly susceptible to neutralization by sera from oth-er clades[J].J Virology,1998;72(10):7840-7845.
  • 9Cao J,Sullivan N,Desjardin E et al.Replication and neutralization ofhuman immunodeficiency virus type 1 lacking the V1 and V2 variableloops of the gp120 envelope glycoprotein[J].J Virology,1997;71(12):9808-9812.
  • 10Pinter A,Honnen W J,He Y et al.The V1/V2 domain of gp120 is aglobal regulator of the sensitivity of primary human immunodeficiencyvirus type 1 isolates to neutralization by antibodies commonly inducedupon infection[J].J Virology,2004;78(10):5205-5215.

共引文献2

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部